The optimized conditions for the in vitro micronucleus (MN) test procedures using chamber slides
スポンサーリンク
概要
- 論文の詳細を見る
Optimized conditions for an in vitro micronucleus (MN) test procedure were defined using a chamber slide that enabled the preparation of fine specimens without undergoing complicating procedures using culture dishes. The issues investigated are 1) the effect of slide materials on the adhesion of cells, 2) the number of seeding cells necessary to obtain an adequate number of cells for observation and 3) effects of hypotonic treatment and fixation on the cytoplasmic : nuclear area ratio. In addition, we determined cell viability in each chamber using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The results of the investigation were as follows : 1) cell adhesion was best using plastic slides, 2) the optimum number of cells for seeding was 6.6×10^3 cells/cm^2, 3) the best condition for hypotonic treatment was incubation in 75mM KCl at 37℃ for 5 min, and 4) the best condition for fixation was treatment of cells twice for about 2 min in ice-cold methanol containing 6% acetic acid. Finally, the result of the MTT assay correlated with the number of viable cells in chamber as determined by the trypan blue dye exclusion assay. An in vitro MN test was conducted under these conditions using the known clastogens, Mitomycin C and dimethylnitrosamine. These clastogens dose-dependently induced a significant increase in the number of micronucleated cells with positive responses at concentrations approximately 10 times lower than those of the chromosomal aberration test. On the other hand, the frequency of micronucleated cells in the solvent control was stable and low (0.4-1.7%). These results indicated that the in vitro MN test has a high level of sensitivity to clastogens. It was concluded that the in vitro MN test using chamber slides is a rapid, simple and sensitive method to detect clastogens.
- 日本環境変異原学会の論文
- 2005-11-30
著者
-
Motegi Akira
Toxicology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Yamamoto Mika
Toxicology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Seki Jiro
Toxicologic Pathology Drug Safety Res. Laboratories Astellas Pharma Inc.
-
Seki Jiro
Toxicology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
MIYAMAE Youichi
Toxicology Research Laboratories, Fujisawa Pharmaceutical Co. Ltd.
-
Miyamae Youichi
Toxicology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
関連論文
- Collaborative work on evaluation of ovarian toxicity : 12) Effects of 2- or 4-week repeated dose studies and fertility study of indomethacin in female rats
- Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats
- MUTAGENICITY TESTS OF POLYOXYETHYLENE HYDROGENATED CASTOR OIL 60 (HCO-60)
- The optimized conditions for the in vitro micronucleus (MN) test procedures using chamber slides